Evaluation of an Automated Wall-mounted Far Ultraviolet-C Light Technology for Continuous or Intermittent Decontamination of Candida auris on Surfaces
Article Sidebar
Main Article Content
Abstract
Background: Technologies that provides safe and effective decontamination of surfaces and equipment between episodes of manual cleaning could be an important advance in efforts to
prevent transmission of the emerging fungal pathogen Candida auris.
Methods: We tested the efficacy of a novel wall-mounted far ultraviolet-C (UV-C) light technology that delivers far UV-C, when people are not detected within the field of illumination, against C. auris isolates from clades I, II, III, and IV using a quantitative disk carrier test method. In an equipment room, we examined the efficacy of the technology in reducing an isolate of C. auris from clade IV inoculated on multiple sites on portable devices.
Results: The far UV-C technology reduced isolates from all 4 clades of C. auris by >3 log10 colony-forming units (CFU) after an 8-hour exposure on steel disks. For the clade IV isolate, similar reductions were achieved on glass and plastic carriers. In the equipment room, the technology reduced C. auris inoculated on multiple sites on portable equipment by >2 log10 CFU in 4 hours.
Conclusions: The far UV-C technology could be useful for decontamination of surfaces and equipment between episodes of manual cleaning. Additional studies are needed to evaluate the use of the technology in clinical settings.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. Candida auris: Centers for Disease Control and Prevention; 2023 [updated September 26, 2023; cited 2024 February 11]. Available from: https://www.cdc.gov/fungal/candida-auris/index.html.
2. Lyman M, Forsberg K, Sexton DJ, Chow NA, Lockhart SR, Jackson BR, Chiller T. Worsening Spread of Candida auris in the United States, 2019 to 2021. Ann Intern Med. 2023;176(4):489-95. doi: 10.7326/m22-3469. PubMed PMID: 36940442.
3. Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species. Infect Control Hosp Epidemiol. 2017;38(9):1107-9. doi: 10.1017/ice.2017.127. PubMed PMID: 28693657.
4. Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, Griffiths D, George S, Butcher L, Morgan M, Newnham R, Sunderland M, Clarke T, Foster D, Hoffman P, Borman AM, Johnson EM, Moore G, Brown CS, Walker AS, Peto TEA, Crook DW, Jeffery KJM. A Candida auris Outbreak and Its Control in an Intensive Care Setting. N Engl J Med. 2018;379(14):1322-31. doi: 10.1056/NEJMoa1714373. PubMed PMID: 30281988.
5. Haq MF, Pearlmutter BS, Cadnum JL, Donskey CJ. Efficacy of 23 commonly used liquid disinfectants against Candida auris isolates from the 4 major clades. Infect Control Hosp Epidemiol. 2024;45(1):127-31. doi: 10.1017/ice.2023.157. PubMed PMID: 37528766.
6. Kumar J, Eilertson B, Cadnum JL, Whitlow CS, Jencson AL, Safdar N, Krein SL, Tanner WD, Mayer J, Samore MH, Donskey CJ. Environmental Contamination with Candida Species in Multiple Hospitals Including a Tertiary Care Hospital with a Candida auris Outbreak. Pathog Immun. 2019;4(2):260-70. doi: 10.20411/pai.v4i2.291. PubMed PMID: 31768483; PMCID: PMC6827507.
7. Sansom SE, Gussin GM, Schoeny M, Singh RD, Adil H, Bell P, Benson EC, Bittencourt CE, Black S, Del Mar Villanueva Guzman M, Froilan MC, Fukuda C, Barsegyan K, Gough E, Lyman M, Makhija J, Marron S, Mikhail L, Noble-Wang J, Pacilli M, Pedroza R, Saavedra R, Sexton DJ, Shimabukuro J, Thotapalli L, Zahn M, Huang SS, Hayden MK. Rapid Environmental Contamination with Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients. Clin Infect Dis. 2023. doi: 10.1093/cid/ciad752. PubMed PMID: 38059527.
8. Blatchley Iii ER, Brenner DJ, Claus H, Cowan TE, Linden KG, Liu Y, Mao T, Park S-J, Piper PJ, Simons RM, Sliney DH. Far UV-C radiation: An emerging tool for pandemic control. Critical Reviews in Environmental Science and Technology. 2023;53(6):733-53. doi: 10.1080/10643389.2022.2084315.
9. Donskey CJ. Continuous surface and air decontamination technologies: Current concepts and controversies. Am J Infect Control. 2023;51(11s):A144-a50. doi: 10.1016/j.ajic.2023.03.017. PubMed PMID: 37890945.
10. Hessling M, Haag R, Sieber N, Vatter P. The impact of far-UVC radiation (200-230 nm) on pathogens, cells, skin, and eyes - a collection and analysis of a hundred years of data. GMS Hyg Infect Control. 2021;16:Doc07. doi: 10.3205/dgkh000378. PubMed PMID: 33643774; PMCID: PMC7894148.
11. Welch D, Aquino de Muro M, Buonanno M, Brenner DJ. Wavelength-dependent DNA Photodamage in a 3-D human Skin Model over the Far-UVC and Germicidal UVC Wavelength Ranges from 215 to 255 nm. Photochem Photobiol. 2022;98(5):1167-71. doi: 10.1111/php.13602. PubMed PMID: 35104367; PMCID: PMC9544172.
12. Sugihara K, Kaidzu S, Sasaki M, Ichioka S, Takayanagi Y, Shimizu H, Sano I, Hara K, Tanito M. One-year Ocular Safety Observation of Workers and Estimations of Microorganism Inactivation Efficacy in the Room Irradiated with 222-nm Far Ultraviolet-C Lamps. Photochem Photobiol. 2023;99(3):967-74. doi: 10.1111/php.13710. PubMed PMID: 36081379.
13. Kousha O, O’Mahoney P, Hammond R, Wood K, Eadie E. 222 nm Far-UVC from filtered Krypton-Chloride excimer lamps does not cause eye irritation when deployed in a simulated office environment. Photochem Photobiol. 2024;100(1):137-45. doi: 10.1111/php.13805. PubMed PMID: 37029739; PMCID: PMC10952573.
14. Memic S, Osborne AO, Cadnum JL, Donskey CJ. Efficacy of a far-ultraviolet-C light technology for continuous decontamination of air and surfaces. Infect Control Hosp Epidemiol. 2024;45(1):132-4. doi: 10.1017/ice.2023.159. PubMed PMID: 37529841.
15. Chatterjee P, Choi H, Ochoa B, Garmon G, Coppin JD, Allton Y, Lukey J, Williams MD, Navarathna D, Jinadatha C. Clade-specific variation in susceptibility of Candida auris to broad-spectrum ultraviolet C light (UV-C). Infect Control Hosp Epidemiol. 2020;41(12):1384-7. doi: 10.1017/ice.2020.410. PubMed PMID: 33046172; PMCID: PMC7720409.
16. Pearlmutter BS, Haq MF, Cadnum JL, Jencson AL, Carlisle M, Donskey CJ. Efficacy of relatively low-cost ultraviolet-C light devices against Candida auris. Infect Control Hosp Epidemiol. 2022;43(6):747-51. doi: 10.1017/ice.2021.206. PubMed PMID: 34011417.
17. Standard Quantitative Disk Carrier Test Method for Determining Bactericidal, Virucidal, Fungicidal, Mycobactericidal, and Sporicidal Activities of Chemicals. West Conshohocken, PA: ASTM International; 2011.
18. Standard practice for determining antimicrobial efficacy of ultraviolet germicidal irradiation against microorganisms on carriers with simulated soil. West Conshohocken, PA: ASTM International; 2018.
19. Lemons AR, McClelland TL, Martin SB, Jr., Lindsley WG, Green BJ. Inactivation of the multi-drug resistant pathogen Candida auris using ultraviolet germicidal irradiation (UVGI). J Hosp Infect. 2020. doi: 10.1016/j.jhin.2020.04.011. PubMed PMID: 32283175; PMCID: PMC7748379.
20. Vitzilaiou E, Kuria AM, Siegumfeldt H, Rasmussen MA, Knøchel S. The impact of bacterial cell aggregation on UV inactivation kinetics. Water Res. 2021;204:117593. doi: 10.1016/j.watres.2021.117593. PubMed PMID: 34482094.
21. Standard Operating Procedure for Quantitative Method for Evaluating the Efficacy of Antimicrobial Products against Candida auris on Hard, Non-Porous Surfaces. SOP Number: MB-35-03: US Environmental Protection Agency Office of Pesticide Programs; [updated October 12, 2021]. Available from: https://www.epa.gov/system/files/documents/2021-10/mb-35-03.pdf.
22. Redmond SN, Cadnum JL, Silva SY, Pearlmutter BS, Jencson AL, Alhmidi H, Wilson BM, Donskey CJ. Evaluation of a continuously active disinfectant for decontamination of portable medical equipment. Infect Control Hosp Epidemiol. 2022;43(3):387-9. doi: 10.1017/ice.2021.66. PubMed PMID: 34034834; PMCID: PMC8961336.
23. Cadnum JL, Memic S, Jencson AL, Donskey CJ. Why is there a discrepancy between laboratory test results and real-world efficacy of continuously active quaternary ammonium disinfectants? Infect Control Hosp Epidemiol. 2024:1-3. doi: 10.1017/ice.2024.15. PubMed PMID: 38343341.